Montpellier Cedex 5

• Reduced post-transplant cyclophosphamide dose in patients undergoing haploidentical hematopoietic stem cell transplantation for hematologica … Pending
  2024-519986-23-00 5 The study will involve adult women and men from 16 French centers who
• Open-label Extension of KarXT + KarX-EC for Agitation in Alzheimer’s Disease Pending
  2024-519994-20-00 5 Agitation Associated with Alzheimer’s Disease
• Lenalidomide versus methotrexate in difficult-to-treat cutaneous lupus erythematosus Pending
  2024-520089-70-00 5 Cutaneous lupus erythematosus
• Multicenter, randomized, double-blinded, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in pa … Pending
  2024-520140-42-00 5 Patients with primary HPV high-grade squamous intra-epithelial lesions
• “Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicen … Pending
  2024-520414-21-00 5 Adult patients with a LVOS with large core within 9 hours of symptoms
• Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial Pending
  2025-520573-39-00 6 Ultra High Risk of psychosis and first episode psychosis
• Evaluation of the efficacy and safety of bimekizumab (BZK) or adalimumab (ADA) in the treatment of anterior chest wall pain associated with … Pending
  2025-520632-42-00 5 axial or predominantly axial SpA with or without psoriasis
• Optimal Duration of Antibiotic Therapy in Drained Pyogenic Liver Abscess: 3 weeks versus 6 weeks, a non-inferiority trial Pending
  2025-520940-14-00 6 Pyogenic liver abscess
• A Phase 2, single arm Multicenter, Study testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants with Relapsed or Refrac … Pending
  2025-521090-14-00 4 Patients with relapsed/refractory symptomatic multiple myeloma (MM)
• BeCALM - Brentuximab vedotin in CutAneous T-cell Lymphomas (CTCL): post-allogeneic hematopoietic stem cell transplant Maintenance Pending
  2025-521093-34-00 5 rare disease
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending
  2025-521113-13-00 10 Early Parkinson’s Disease
• MAINRITSys : Rituximab vs placebo for maintenance in systemic sclerosis – interstitial lung disease Pending
  2025-521331-36-00 10 Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%)
• PALETTE - Trial for personalisation of sepsis treatment in children and adults Pending
  2025-521371-31-00 4 Sepsis
• ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Pending
  2025-521478-32-00 5 PEDIATRIC ACUTE MYOCARDITIS
• A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizu … Pending
  2025-521587-35-00 5 Metastatic colorectal cancer
• Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. Pending
  2025-521923-58-00 4 Intracerebral hemorrhage.
• A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative co … Pending
  2025-522511-42-00 4 Crohn's disease
• Usnoflast Neuromuscular Investigation for Treatment Efficacy in ALS (UNITE-ALS) Pending
  2025-522580-15-00 4 Amyotrophic Lateral Sclerosis (ALS)
• Trial assessing treatment in patients with advanced Lung Cancer and Interstitial Lung Disease Pending
  2025-522790-10-00 4 Non Small Cell Lung Cancer
• Intermediate versus standard dose enoxaparin to prevent venous thromboembolism in severe trauma patients: a multicenter double blind randomi … Pending
  2025-522832-16-00 10 Severe trauma
• An extension study to investigate the long-term safety and tolerability of itepekimab in adult participants with inadequately controlled chr … Pending
  2025-522983-33-00 5 Chronic rhinosinusitis with nasal polyps
• A clinical study of MK-1045 in people with non-Hodgkin lymphoma (MK-1045-008) Pending
  2025-523005-15-00 9 Non-Hodgkin Lymphoma
• Effects of butyrate enemas on postoperative intestinal motility disorders in Hirschsprung’s disease Pending
  2025-523094-42-00 5 Hirschsprung's disease
• Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) Pending
  2025-523389-26-00 5 Relapsed/refractory primary central nervous system lymphoma

Showing 49–72 of 830 trials